Gauzy Ltd. announced on August 8, 2025, changes to its Board of Directors following the company's annual general meeting of shareholders. Alejandro Weinstein, a long-time investor and former Board member, was elected to return to the Board as a Director, with his term commencing November 1, 2025.
Mr. Weinstein brings over 30 years of managerial experience in global companies, including his tenure as CEO of CFR Pharmaceuticals S.A., which he transformed into a publicly listed global pharmaceutical enterprise. His expertise in international growth, mergers and acquisitions, and public company leadership is expected to be instrumental as Gauzy scales its operations.
In conjunction with these changes, Gal Gitter concluded his service on the Board, and Danny Allouche stepped down. Gauzy stated that it is adopting a leaner Board structure to reduce corporate expenses and maintain agility, aiming to enhance strategic oversight and long-term value creation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.